Literature DB >> 28369163

Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.

Nimalan Arinaminpathy, Inkyu Kevin Kim, Paul Gargiullo, Michael Haber, Ivo M Foppa, Manoj Gambhir, Joseph Bresee.   

Abstract

With influenza vaccination rates in the United States recently exceeding 45% of the population, it is important to understand the impact that vaccination is having on influenza transmission. In this study, we used a Bayesian modeling approach, combined with a simple dynamical model of influenza transmission, to estimate this impact. The combined framework synthesized evidence from a range of data sources relating to influenza transmission and vaccination in the United States. We found that, for seasonal epidemics, the number of infections averted ranged from 9.6 million in the 2006-2007 season (95% credible interval (CI): 8.7, 10.9) to 37.2 million (95% CI: 34.1, 39.6) in the 2012-2013 season. Expressed in relative terms, the proportion averted ranged from 20.8% (95% CI: 16.8, 24.3) of potential infections in the 2011-2012 season to 47.5% (95% CI: 43.7, 50.8) in the 2008-2009 season. The percentage averted was only 1.04% (95% CI: 0.15, 3.2) for the 2009 H1N1 pandemic, owing to the late timing of the vaccination program in relation to the pandemic in the Northern hemisphere. In the future, further vaccination coverage, as well as improved influenza vaccines (especially those offering better protection in the elderly), could have an even stronger effect on annual influenza epidemics. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Bayesian inference; herd immunity; influenza; mathematical modeling; vaccination

Mesh:

Substances:

Year:  2017        PMID: 28369163      PMCID: PMC5860220          DOI: 10.1093/aje/kwx037

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  43 in total

1.  Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission.

Authors:  P van den Driessche; James Watmough
Journal:  Math Biosci       Date:  2002 Nov-Dec       Impact factor: 2.144

2.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

3.  Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren.

Authors:  A S Monto; F M Davenport; J A Napier; T Francis
Journal:  J Infect Dis       Date:  1970 Jul-Aug       Impact factor: 5.226

Review 4.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Authors:  Michael T Osterholm; Nicholas S Kelley; Alfred Sommer; Edward A Belongia
Journal:  Lancet Infect Dis       Date:  2011-10-25       Impact factor: 25.071

Review 5.  Influenza: old and new threats.

Authors:  Peter Palese
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

Review 6.  Influenza: lessons from past pandemics, warnings from current incidents.

Authors:  Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Nat Rev Microbiol       Date:  2005-08       Impact factor: 60.633

7.  Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland.

Authors:  Wieslawa Janaszek; Nigel J Gay; Wlodzimierz Gut
Journal:  Vaccine       Date:  2003-01-17       Impact factor: 3.641

8.  Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

Authors:  L G Rudenko; A N Slepushkin; A S Monto; A P Kendal; E P Grigorieva; E P Burtseva; A R Rekstin; A L Beljaev; V E Bragina; N Cox
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

9.  Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.

Authors:  Ivo M Foppa; Po-Yung Cheng; Sue B Reynolds; David K Shay; Cristina Carias; Joseph S Bresee; Inkyu K Kim; Manoj Gambhir; Alicia M Fry
Journal:  Vaccine       Date:  2015-03-23       Impact factor: 3.641

10.  Environmental predictors of seasonal influenza epidemics across temperate and tropical climates.

Authors:  James D Tamerius; Jeffrey Shaman; Wladimir J Alonso; Wladmir J Alonso; Kimberly Bloom-Feshbach; Christopher K Uejio; Andrew Comrie; Cécile Viboud
Journal:  PLoS Pathog       Date:  2013-03-07       Impact factor: 6.823

View more
  12 in total

1.  Dynamic Perspectives on the Search for a Universal Influenza Vaccine.

Authors:  Chadi M Saad-Roy; Adrian B McDermott; Bryan T Grenfell
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

2.  Challenges in estimating influenza vaccine effectiveness.

Authors:  Kylie E C Ainslie; Michael Haber; Walt A Orenstein
Journal:  Expert Rev Vaccines       Date:  2019-05-31       Impact factor: 5.217

3.  An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States.

Authors:  Jerome I Tokars; Melissa A Rolfes; Ivo M Foppa; Carrie Reed
Journal:  Vaccine       Date:  2018-10-14       Impact factor: 3.641

4.  Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season.

Authors:  Melissa A Rolfes; Brendan Flannery; Jessie R Chung; Alissa O'Halloran; Shikha Garg; Edward A Belongia; Manjusha Gaglani; Richard K Zimmerman; Michael L Jackson; Arnold S Monto; Nisha B Alden; Evan Anderson; Nancy M Bennett; Laurie Billing; Seth Eckel; Pam Daily Kirley; Ruth Lynfield; Maya L Monroe; Melanie Spencer; Nancy Spina; H Keipp Talbot; Ann Thomas; Salina M Torres; Kimberly Yousey-Hindes; James A Singleton; Manish Patel; Carrie Reed; Alicia M Fry
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 20.999

5.  Population implications of the deployment of novel universal vaccines against epidemic and pandemic influenza.

Authors:  N Arinaminpathy; S Riley; W S Barclay; C Saad-Roy; B Grenfell
Journal:  J R Soc Interface       Date:  2020-03-04       Impact factor: 4.118

6.  Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?

Authors:  Ryan E Malosh; Joshua G Petrie; Amy Callear; Rachel Truscon; Emileigh Johnson; Richard Evans; Latifa Bazzi; Caroline Cheng; Mark S Thompson; Emily T Martin; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 20.999

7.  Challenges of evaluating and modelling vaccination in emerging infectious diseases.

Authors:  Zachary J Madewell; Natalie E Dean; Jesse A Berlin; Paul M Coplan; Kourtney J Davis; Claudio J Struchiner; M Elizabeth Halloran
Journal:  Epidemics       Date:  2021-10-05       Impact factor: 5.324

8.  Effects of Influenza Vaccination in the United States During the 2018-2019 Influenza Season.

Authors:  Jessie R Chung; Melissa A Rolfes; Brendan Flannery; Pragati Prasad; Alissa O'Halloran; Shikha Garg; Alicia M Fry; James A Singleton; Manish Patel; Carrie Reed
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 20.999

9.  Meditation or exercise for preventing acute respiratory infection (MEPARI-2): A randomized controlled trial.

Authors:  Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Roger Brown; Aleksandra E Zgierska; Shari Barlow; Supriya Hayer; Jodi H Barnet; Elisa R Torres; Christopher L Coe
Journal:  PLoS One       Date:  2018-06-22       Impact factor: 3.240

10.  Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.

Authors:  Alexandra B Hogan; Peter Winskill; Oliver J Watson; Patrick G T Walker; Charles Whittaker; Marc Baguelin; Nicholas F Brazeau; Giovanni D Charles; Katy A M Gaythorpe; Arran Hamlet; Edward Knock; Daniel J Laydon; John A Lees; Alessandra Løchen; Robert Verity; Lilith K Whittles; Farzana Muhib; Katharina Hauck; Neil M Ferguson; Azra C Ghani
Journal:  Vaccine       Date:  2021-04-08       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.